Javelin Pharmaceuticals, Inc

(AMEX:JAV)

1.37

-0.08 (-5.52%)

Jan 07 - Close

Open
1.45
High
1.47
Low
1.36
Vol.
147.10K
Mkt Cap
87.90M
52Wk High
4.39
52Wk Low
0.40
Avg. Vol.
151.30K
P/E (Trailing)
-1.85
Beta
0.00
Short %
5.20%
Div. Yield
—

After-Hours 1.38 +0.01 (0.73%) Wed, 7 Jan 2009 7:40 PM

Company Profile

Javelin Pharmaceuticals, Inc

125 CambridgePark Drive

Cambridge, MA 02140

United States - Map

Phone: (617) 349-4500

Fax: (617) 349-4505

Website: www.javelinpharmaceuticals.com

State of incorporation: Delaware

CEO: Martin J. Driscoll

Employees: 40

Sector: Healthcare

Industry Group: Drugs

Industry: Drug Manufacturers - Major

Pharmaceutical Preparation Manufacturing

A development stage company, which is engaged in the research, development and commercialization of innovative treatments for the relief of moderate to severe pain.

Recent news for JAV

Members owning JAV also own

POT (66.67%), MS (66.67%), ANAD (33.33%), FSLR (33.33%), BUD (33.33%)

Member sentiment (?)    Neutral

- MarketGuru Blog network-

Top members owning JAV

* Average monthly return vs. S&P 500

Recent opinions on JAV

More opinions on JAV »